Publication: Severe community-acquired pneumonia in general medical wards: Outcomes and impact of initial antibiotic selection
Issued Date
2019-10-16
Resource Type
ISSN
14712466
Other identifier(s)
2-s2.0-85073470274
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Pulmonary Medicine. Vol.19, No.1 (2019)
Suggested Citation
Phunsup Wongsurakiat, Napat Chitwarakorn Severe community-acquired pneumonia in general medical wards: Outcomes and impact of initial antibiotic selection. BMC Pulmonary Medicine. Vol.19, No.1 (2019). doi:10.1186/s12890-019-0944-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51362
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Severe community-acquired pneumonia in general medical wards: Outcomes and impact of initial antibiotic selection
Author(s)
Abstract
© 2019 The Author(s). Background: Most international guidelines recommend empirical therapy for community-acquired pneumonia (CAP) to be based on site of care. Some patients with severe CAP are managed in general wards because of limited intensive care unit (ICU) bed or because of unrecognition of the pneumonia severity. Appropriate initial antibiotic treatment for severe CAP outside ICU has not yet been established. This study aimed to determine the prevalence and the impact of initial antibiotic selection on the outcomes of patients with severe CAP who were admitted and managing in general wards. Methods: This prospective observational study included consecutive patients hospitalized for presumed CAP in general wards over a 1-year period. Severe CAP was identified using the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) criteria. Initial antibiotic treatment in the first 24 h were collected. The primary outcome was the rate of unfavorable outcome (composite outcome of treatment failure and in-hospital death). The secondary outcome was the number of hospital-free days assessed 30 days after enrollment into the study. Results: There were 94 patients hospitalized with CAP of which 50 (53.2%) patients were compatible with severe CAP. An etiologic diagnosis was found in 43 (45.8%) patients. The most common pathogens identified in patients with severe CAP were Staphylococcus aureus (28.6%) and Klebsiella pneumoniae (28.6%), followed by Pseudomonas aeruginosa (17.9%). Patients with severe CAP had significantly more positive blood culture than patients with non-severe CAP (24% VS 4.5%; p =.008). Initial antibiotic treatment were discordant with the IDSA/ATS guidelines in 42% of all patients hospitalized with CAP, and 52% of patients with severe CAP. Multivariate analysis revealed that age (OR 1.1, 95% CI 1.01-1.1) and initial antibiotic treatment discordant to guidelines for severe CAP in ICU (OR 4.6, 95% CI 1.3-17.1) were independent risk factors of the unfavorable outcome of patients with severe CAP. Patients with unfavorable outcome had lower number of hospital-free days than patients with favorable outcome (5.2 ± 8 days VS 18 ± 7.1 days; p <.001). Conclusions: Patients with severe CAP outside ICU should be recognized for appropriate initial antibiotic selection to improve outcomes.